Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 6923629, 11 pages
https://doi.org/10.1155/2017/6923629
Research Article

Investigation into Hypoglycemic, Antihyperlipidemic, and Renoprotective Potentials of Dennettia tripetala (Pepper Fruit) Seed in a Rat Model of Diabetes

1Department of Medical Laboratory Sciences, Faculty of Health Sciences and Technology, College of Medicine, University of Nigeria, Enugu Campus, Enugu, Nigeria
2Department of Chemical Pathology, College of Medicine, Nnamdi Azikiwe University, Nnewi, Nigeria

Correspondence should be addressed to Innocent Anioke; gn.ude.nnu@ekoina.tneconni

Received 20 April 2017; Accepted 9 August 2017; Published 17 October 2017

Academic Editor: Naoaki Sakata

Copyright © 2017 Innocent Anioke et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Ali, A. Kahn, and M. Mosihuzzaman, “Studies on the hypoglycemic effects of fruit pulp, seed and whole plant of Momordica cheranta on normal and diabetic rat model,” Planta Medica, vol. 56, pp. 408–412, 1993. View at Google Scholar
  2. T. Susheela, B. Padma, T. Jane, R. Narender, and P. Reddy, “Evaluation of hypoglycemic and anti-diabetic effect of Melia dubia fruit in mice,” Current Science, vol. 94, no. 9, pp. 1191–1195, 2008. View at Google Scholar
  3. A. Pontiroli, A. Ealdera, and G. Pozza, “Diabetes,” Metabolism Reveiws, vol. 10, article 31, 1994. View at Publisher · View at Google Scholar
  4. G. Gruden, P. C. Perin, and G. Camussi, “Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology,” Current Diabetes Reviews, vol. 1, no. 1, pp. 27–40, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Shaw, R. Sicree, and P. Zimmet, “Global estimates of the prevalence of diabetes for 2010 and 2030,” Diabetes Research and Clinical Practice, vol. 87, pp. 4–14, 2010. View at Google Scholar
  6. O. Akinkugbe and O. Akinyanju, “Final report. National Survey on Non-Communicable Disease,” Tech. Rep., Federal Ministry of Health, Lagos, Nigeria.
  7. R. Oputa and S. Chinenye, “Diabetes in Nigeria a translational medicine approach,” African Journal of Diabetes Medicine, vol. 23, no. 1, pp. 7–10, 2015. View at Google Scholar
  8. C. U. Osuji, B. A. Nzerem, C. E. Dioka, S. C. Meludu, and E. I. Onwubuya, “Prevalence of diabetes mellitus in a group of women attending “August meeting” at Naze South East Nigeria,” Journal of Diabetes Mellitus, vol. 02, no. 03, pp. 321–326, 2012. View at Publisher · View at Google Scholar
  9. A. O. Ogbera, S. Chinenye, A. Onyekwere, and O. Fasanmade, “Prognostic indices of diabetes mortality,” Ethnicity and Disease, vol. 17, no. 4, pp. 721–725, 2007. View at Google Scholar · View at Scopus
  10. O. A. Komolafe, D. O. Adeyemi, S. O. Adewole, and E. M. Obuotor, “Streptozotocin-induced diabetes alters the serum lipid profiles of adult wistar rats,” The Internet Journal of Cardiovascular Research, vol. 7, no. 1, 2009. View at Google Scholar · View at Scopus
  11. A. Ramachandra, C. Snehalata, and V. Vishwanathan, “Burden of Type 2 diabetes and it’s complications-the Indian scenerio,” Current Science, vol. 83, pp. 1471–1477, 2002. View at Google Scholar
  12. T. Merlin, T. Con, M. Richard, and J. George, “Anaemia in diabetes: an emerging complication of microvascular disease,” Current Diabetes Reviews, vol. 1, pp. 107–126, 2005. View at Google Scholar
  13. M. J. Fowler, “Microvascular and macrovascular complications of diabetes,” Clinical Diabetes, vol. 26, no. 2, pp. 77–82, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Lee, H.-I. Lee, K.-I. Seo et al., “Effects of ursolic acid on glucose metabolism, the polyol pathway and dyslipidemia in non-obese type 2 diabetic mice,” Indian Journal of Experimental Biology, vol. 52, no. 7, pp. 683–691, 2014. View at Google Scholar · View at Scopus
  15. S. Raju and B. Raju, Illustrated Medical Biochemistry, Jaypee Brothers Medical Publishers, New Delhi, India, 2nd edition, 2010.
  16. E. Matteucci and O. Giampietro, “Oxidative stress in families of type 1 diabetic patients,” Diabetes Care, vol. 23, no. 8, pp. 1182–1186, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. L. W. Oberley, “Free radicals and diabetes,” Free Radical Biology and Medicine, vol. 5, no. 2, pp. 113–124, 1988. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Baynes and S. Thorpe, “The role of oxidative stress in diabetic complications,” Current Opinion in Endocrinology, vol. 3, pp. 277–284, 1997. View at Google Scholar
  19. B. Lipinski, “Pathophysiology of oxidative stress in diabetes mellitus,” Journal of Diabetes and Its Complications, vol. 15, no. 4, pp. 203–210, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. R. MacIsaac and G. Jerums, “Management of early Diabetic Nephropathy,” Diabetes Voice, vol. 48 (Special Issue), pp. 15–18, 2003. View at Google Scholar
  21. V. M. Altan, “The pharmacology of diabetic complications,” Current Medicinal Chemistry, vol. 10, no. 15, pp. 1317–1327, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Hattersley, “Multiple facts of diabetes in young people,” Current Science, vol. 82, pp. 273–276, 2002. View at Google Scholar
  23. M. Ravid, L. Neumann, and M. Lishner, “Plasma lipids and the progression of nephropathy in diabetes mellitus type II: Effect of ACE inhibitors,” Kidney International, vol. 47, no. 3, pp. 907–910, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. M.-A. Gall, P. Hougaard, K. Borch-Johnsen, and H.-H. Parving, “Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study,” British Medical Journal, vol. 314, no. 7083, pp. 783–788, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Klein, B. E. K. Klein, S. E. Moss, K. J. Cruickshanks, and P. C. Brazy, “The 10-year incidence of renal insufficiency in people with type 1 diabetes,” Diabetes Care, vol. 22, no. 5, pp. 743–751, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Rosalind, K. Biman, and B. Satya, “Antihyperglycemic and Antihyperlipidemic activity of Ficus Auriculata lour leaf extract in streptozotocin in induced diabetic mice,” World Journnal of Pharmacy and Pharmaceutical Sciences, vol. 3, no. 1, pp. 412–427, 2013. View at Google Scholar
  27. WHO, Regulatory Situation of Herbal Medicines: A Worldwide Review, World Health Organization, Geneva, Switzerland, 2013.
  28. B. Beyene, B. Beyene, and H. Deribe, “Review on application and management of medicinal plants for the livelihood of the local community,” Journal of Resources Development and Management, vol. 22, pp. 33–39, 2016. View at Google Scholar
  29. WHO, “Expert Committee on Diabetes Mellitus,” Technical Report Series, Geneva, Switzerland, 1980. View at Google Scholar
  30. L. Verma, A. Khatri, B. Kaushik, U. K. Patil, and R. S. Pawar, “Antidiabetic activity of Cassia occidentalis (Linn) in normal and alloxan-induced diabetic rats,” Indian Journal of Pharmacology, vol. 42, no. 4, pp. 224–228, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Nickavar, M. Kamalinejad, and H. Izadpanah, “In vitro free radical scavenging activity of five Salvia species,” Pakistan journal of Pharmaceutical Sciences, vol. 20, no. 4, pp. 291–294, 2007. View at Google Scholar · View at Scopus
  32. E. Melo, J. Filho, and N. Guerra, “Characterization of antioxidant compounds in aqueous coriander extracts (Coriander sativumL.),” LWT-Food Science and Technology, vol. 38, pp. 15–19, 2005. View at Google Scholar
  33. B. Elitok, “Efficacy of herbal remedies in the treatment of cardiovascular diseases in human and animals,” Kocatepe Veterinary Journal, vol. 6, no. 1, pp. 63–68, 2013. View at Publisher · View at Google Scholar
  34. D. Okwu, F. Morah, and E. Anam, “Isolation and characterization of phenanthrenic alkaloid uvariopsine from Dennettia tripetala fruits,” Medicinal and Aromatic Plant Science and Biotechnology, vol. 27, pp. 496–498, 2005. View at Google Scholar
  35. S. C. Achinewhu, C. C. Ogbonna, and A. D. Hart, “Chemical composition of indigenous wild herbs, spices, fruits, nuts and leafy vegetables used as food,” Plant Foods for Human Nutrition, vol. 48, no. 4, pp. 341–348, 1995. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Iwu, “Food for medicine,” in Dietary Plants And Masticastors as Sources of Biologically Active Substances, pp. 303–310, University of Ife Press, Ife, Nigeria, 1989. View at Google Scholar
  37. A. Sofowora, Screening Plants for Bioactive Agents. Medical Plants and Traditional Medicinal in Africa, Spectrum Books, Ibadan, Nigeria, 1993.
  38. G. Trease and W. Evans, Parmacognosy, vol. 393, Saunders Publishers, London, UK, 2002.
  39. J. Harborne, Phytochemical Methods: A Guide to Modern Techniques of Plant Analysis, Chapman and Hall Publishers, London, UK, 2nd edition, 1973.
  40. H. R. Ferdowsian and N. Beck, “Ethical and scientific considerations regarding animal testing and research,” PLoS ONE, vol. 6, no. 9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Lorke, “A new approach to practical acute toxicity testing,” Archives of Toxicology, vol. 54, no. 4, pp. 275–287, 1983. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Lenzen, “The mechanisms of alloxan- and streptozotocin-induced diabetes,” Diabetologia, vol. 51, no. 2, pp. 216–226, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Luzi and G. Pozza, “Glibenclamide: an old drug with a novel mechanism of action?” Acta Diabetologica, vol. 34, no. 4, pp. 239–244, 1997. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Trinder, “CHOD-PAD enzymatic colorimetric method of cholesterol determination,” Annals of Clinical Biochemistry, vol. 6, pp. 24–27, 1969. View at Publisher · View at Google Scholar
  45. P. Fossati and L. Prencipe, “Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide,” Clinical Chemistry, vol. 28, no. 10, pp. 2077–2080, 1982. View at Google Scholar · View at Scopus
  46. D. Fredrickson, R. Levy, and R. Lees, “Fat transport in lipoprotein- an integrated approach to mechanisms and disorders,” The New England Journal of Medicine, vol. 276, no. 5, pp. 273–281, 1967. View at Publisher · View at Google Scholar
  47. J. J. Albers, G. R. Warnick, and M. C. Chenng, “Quantitation of high density lipoproteins,” Lipids, vol. 13, no. 12, pp. 926–932, 1978. View at Publisher · View at Google Scholar · View at Scopus
  48. T. Ng, C. The, M. Vidyadaran et al., “A critical evaluation of high density lipoprotein cholesterol as an index of coronary artery disease risk in Malaysians,” Malaysian Journal of Nutrition, vol. 3, pp. 61–70, 1997. View at Google Scholar
  49. J. C. Ozougwu, K. C. Obimba, C. D. Belonwu, and C. B. Unakalamba, “The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus,” Journal of Physiology and Pathophysiology, vol. 4, no. 4, pp. 46–57, 2013. View at Publisher · View at Google Scholar
  50. I. J. Atangwho, K. B. Yin, M. I. Umar, M. Ahmad, and M. Z. Asmawi, “Vernonia amygdalina simultaneously suppresses gluconeogenesis and potentiates glucose oxidation via the pentose phosphate pathway in streptozotocin-induced diabetic rats,” BMC Complementary and Alternative Medicine, vol. 14, no. 1, article 426, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Kumar, D. Kerins, and T. Walther, “Cardiovascular safety of anti-diabetic drugs,” European Heart Journal Cardiovascular Pharmacotherapy, vol. 2, pp. 32–43, 2016. View at Publisher · View at Google Scholar
  52. A. Chaudhury, C. Duvoor, V. S. Reddy Dendi et al., “Clinical review of antidiabetic drugs: Implications for type 2 diabetes mellitus management,” Frontiers in Endocrinology, vol. 8, no. 6, pp. 1–12, 2017. View at Publisher · View at Google Scholar · View at Scopus
  53. R. G. Moses, “Combination therapy for patients with Type 2 diabetes: repaglinide in combination with metformin,” Expert Review of Endocrinology and Metabolism, vol. 5, no. 3, pp. 331–342, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Unnikrishnan, V. Veerapur, Y. Yogendra Nayak, P. Mudgal, and G. Mathew, “Antidiabetic, antihyperlipidemic and antioxidant effects of the flavonoids,” in Polyphenols in Human Health and Disease, vol. 1, pp. 143–161, 2014. View at Google Scholar
  55. G. Boden, P. Cheung, M. Mozzoli, and S. K. Fried, “Effect of thiazolidinediones on glucose and fatty acid metabolism in patients with type 2 diabetes,” Metabolism: Clinical and Experimental, vol. 52, no. 6, pp. 753–759, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. A. J. Krentz and C. J. Bailey, “Oral antidiabetic agents: current role in type 2 diabetes mellitus,” Drugs, vol. 65, no. 3, pp. 385–411, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. K. Hardy and S. McNutty, “Oral hypoglycaemic agent,” Medical Digest, vol. 23, pp. 5–9, 1997. View at Google Scholar
  58. N. A. Trivedi, B. Mazumdar, J. D. Bhatt, and K. G. Hemavathi, “Effect of shilajit on blood glucose and lipid profile in alloxan-induced diabetic rats,” Indian Journal of Pharmacology, vol. 36, no. 6, pp. 373–376, 2004. View at Google Scholar · View at Scopus
  59. R. Vinayagam and B. Xu, “Antidiabetic properties of dietary flavonoids: A cellular mechanism review,” Nutrition and Metabolism, vol. 12, no. 1, article 60, 2015. View at Publisher · View at Google Scholar · View at Scopus
  60. N. Koffi, F. Yvette, and K. Henri, “Effect of aqueous extract of Boerhaavia diffusa leaves in the glycaemia of rabbits,” nternational Journal ofApplied Biology and Pharmaceutical Technology, vol. 2, no. 3, pp. 330–338, 2011. View at Google Scholar
  61. A. Mungle, M. Bodhankar, and K. Chandak, “Antidiabetic potential of Dolichandrone falcata leaves in alloxan induced diabetic rats,” International Journal of Research in Pharmaceutical andBiomedical Sciences, vol. 3, no. 1, pp. 319–324, 2012. View at Google Scholar
  62. A. K. Singh and J. Singh, “Evaluation of anti-diabetic potential of leaves and stem of Flacourtia jangomas in streptozotocin-induced diabetic rats,” Indian Journal of Pharmacology, vol. 42, no. 5, pp. 301–305, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. S. P. Sah, M. L. Sah, V. Juyal, and S. Pandey, “Hypoglycemic activity of aqueous extract of Urtica parviflora roxb. in normoglycemic rats,” International Journal of Phytomedicine, vol. 2, no. 1, pp. 47–51, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Oyedemi, G. Bradley, and A. Afolayan, “Antidiabetic activities of aqueous stem bark extract of Strychnos henningsii Gilg. in streptozotocin-nicotinamide type 2 diabetic rats,” Iranian Journal of Pharmaceutical Research, vol. 11, no. 1, pp. 221–228, 2012. View at Google Scholar
  65. B. Oliver-Bever, Medicinal Plants in Tropical West Africa, Cambridge University Press, London, UK, 1986. View at Publisher · View at Google Scholar
  66. M. D. Ivorra, M. Payá, and A. Villar, “A review of natural products and plants as potential antidiabetic drugs,” Journal of Ethnopharmacology, vol. 27, no. 3, pp. 243–275, 1989. View at Publisher · View at Google Scholar · View at Scopus
  67. A. Rhemann and K. Zaman, “medicinal plants with hypoglycaemic activity,” Journal of Ethnopharmacology, vol. 26, pp. 1–55, 1989. View at Google Scholar
  68. B. Kameswara Rao, P. Renuka Sudarshan, M. D. Rajasekhar, N. Nagaraju, and C. Appa Rao, “Antidiabetic activity of Terminalia pallida fruit in alloxan induced diabetic rats,” Journal of Ethnopharmacology, vol. 85, no. 1, pp. 169–172, 2003. View at Publisher · View at Google Scholar · View at Scopus
  69. J. Girard, P. Ferre, and F. Foufelle, “Mechanism by which carbohydrate regulates expression of genes for glycolytic and lipogenic enzymes,” Annual Review of Nutrition, vol. 17, no. 325, 1997. View at Google Scholar
  70. J. Grimsby, R. Sarabu, W. L. Corbett et al., “Allosteric activators of glucokinase: Potential role in diabetes therapy,” Science, vol. 301, no. 5631, pp. 370–373, 2003. View at Publisher · View at Google Scholar · View at Scopus
  71. J. A. Pfefferkorn, “Strategies for the design of hepatoselective glucokinase activators to treat type 2 diabetes,” Expert Opinion on Drug Discovery, vol. 8, no. 3, pp. 319–330, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. J. J. Hulmi, M. Silvennoinen, M. Lehti, R. Kivelä, and H. Kainulainen, “Altered REDD1, myostatin, and Akt/mTOR/FoxO/MAPK signaling in streptozotocin-induced diabetic muscle atrophy,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 302, no. 3, pp. E307–E315, 2012. View at Publisher · View at Google Scholar · View at Scopus
  73. P. Newsholme, F. Abdulkader, E. Rebelato et al., “Amino acids and diabetes: Implications for endocrine, metabolic and immune function,” Frontiers in Bioscience, vol. 16, no. 1, pp. 315–339, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. D. J. Glass, “Skeletal muscle hypertrophy and atrophy signaling pathways,” International Journal of Biochemistry and Cell Biology, vol. 37, no. 10, pp. 1974–1984, 2005. View at Publisher · View at Google Scholar · View at Scopus
  75. A. Musarò, K. McCullagh, A. Paul et al., “Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle,” Nature Genetics, vol. 27, no. 2, pp. 195–200, 2001. View at Publisher · View at Google Scholar · View at Scopus
  76. M. Miyazaki and K. Esser, “Cellular mechanisms regulating protein synthesis and skeletal muscle hypertrophy in animals,” Journal of Applied Physiology, vol. 106, pp. 1367–1373, 2009. View at Publisher · View at Google Scholar
  77. J. Zhang, P. Zhuang, Y. Wang et al., “Reversal of muscle atrophy by Zhimu-Huangbai herb-pair via Akt/mTOR/FoxO3 signal pathway in streptozotocin-induced diabetic mice,” PLoS ONE, vol. 9, no. 6, article e100918, 2014. View at Publisher · View at Google Scholar · View at Scopus
  78. A. J. Krentz, “Lipoprotein abnormalities and their consequences for patients with type 2 diabetes,” Diabetes, Obesity and Metabolism, vol. 5, no. 1, pp. S19–S27, 2003. View at Publisher · View at Google Scholar · View at Scopus
  79. A. Shirwaikar, K. Rajendran, C. D. Kumar, and R. Bodla, “Antidiabetic activity of aqueous leaf extract of Annona squamosa in streptozotocin-nicotinamide type 2 diabetic rats,” Journal of Ethnopharmacology, vol. 91, no. 1, pp. 171–175, 2004. View at Publisher · View at Google Scholar · View at Scopus
  80. B. Kameswararao, M. M. Kesavulu, and C. Apparao, “Evaluation of antidiabetic effect of Momordica cymbalaria fruit in alloxan-diabetic rats,” Fitoterapia, vol. 74, no. 1-2, pp. 7–13, 2003. View at Publisher · View at Google Scholar · View at Scopus
  81. G. F. Lewis, K. D. Uffelman, L. W. Szeto, B. Weller, and G. Steiner, “Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans,” Journal of Clinical Investigation, vol. 95, no. 1, pp. 158–166, 1995. View at Publisher · View at Google Scholar · View at Scopus
  82. S. Kehlenbrink, S. Koppaka, M. Martin et al., “Elevated NEFA levels impair glucose effectiveness by increasing net hepatic glycogenolysis,” Diabetologia, vol. 55, no. 11, pp. 3021–3028, 2012. View at Publisher · View at Google Scholar · View at Scopus
  83. C. Best and N. Taylor, “Biological effect of insulin,” in Physiological Basis of Medical Practise, W. William and Wilkin, Eds., pp. 245–267, Cambridge University Press, London, UK, 1989. View at Google Scholar
  84. P. Strålfors and R. C. Honnor, “Insulin-induced dephosphorylation of hormone-sensitive lipase. Correlation with lipolysis and cAMP-dependent protein kinase activity,” European Journal of Biochemistry, vol. 182, no. 2, pp. 379–385, 1989. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Jaye, K. J. Lynch, J. Krawiec et al., “A novel endothelial-derived lipase that modulates HDL metabolism,” Nature Genetics, vol. 21, no. 4, pp. 424–428, 1999. View at Publisher · View at Google Scholar · View at Scopus
  86. K.-I. Hirata, H. L. Dichek, J. A. Cioffi et al., “Cloning of a unique lipase from endothelial cells extends the lipase gene family,” Journal of Biological Chemistry, vol. 274, no. 20, pp. 14170–14175, 1999. View at Publisher · View at Google Scholar · View at Scopus
  87. M. G. McCoy, G.-S. Sun, D. Marchadier, C. Maugeais, J. M. Glick, and D. J. Rader, “Characterization of the lipolytic activity of endothelial lipase,” Journal of Lipid Research, vol. 43, no. 6, pp. 921–929, 2002. View at Google Scholar · View at Scopus
  88. Y. Kojima, T. Ishida, L. Sun et al., “Pitavastatin decreases the expression of endothelial lipase both in vitro and in vivo,” Cardiovascular Research, vol. 87, no. 2, pp. 385–393, 2010. View at Publisher · View at Google Scholar · View at Scopus
  89. R. A. Ortíz Cruz, J. L. Cárdenas López, G. A. González Aguilar et al., “Influence of sorghum kafirin on serum lipid profile and antioxidant activity in hyperlipidemic rats (in vitro and in vivo studies),” BioMed Research International, vol. 2015, Article ID 164725, 8 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  90. H. Ginsberg, J. Plutzky, and B. E. Sobel, “A review of metabolic and cardiovascular effects of oral antidiabetic agents: beyond glucose-level lowering,” Journal of Cardiovascular Risk, vol. 6, no. 5, pp. 337–346, 1999. View at Publisher · View at Google Scholar · View at Scopus
  91. H. N. Ginsberg, “Diabetic dyslipidemia: Basic mechanisms underlying the common hypertriglyceridemia and low HDL cholesterol levels,” Diabetes, vol. 45, no. 3, pp. S27–S30, 1996. View at Publisher · View at Google Scholar · View at Scopus
  92. D. B. Panagiotakos, C. Pitsavos, and J. Skoumas, “Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987–2002),” Current Medical Research and Opinion, vol. 19, no. 2, pp. 89–94, 2003. View at Publisher · View at Google Scholar · View at Scopus